2BYP image
Deposition Date 2005-08-03
Release Date 2005-10-05
Last Version Date 2023-12-13
Entry Detail
PDB ID:
2BYP
Keywords:
Title:
Crystal structure of Aplysia californica AChBP in complex with alpha- conotoxin ImI
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.07 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
I 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:SOLUBLE ACETYLCHOLINE RECEPTOR
Chain IDs:A, B, C, D, E
Chain Length:214
Number of Molecules:5
Biological Source:APLYSIA CALIFORNICA
Polymer Type:polypeptide(L)
Molecule:ALPHA-CONOTOXIN IMI
Chain IDs:F, G, H, I, J
Chain Length:12
Number of Molecules:5
Biological Source:CONUS IMPERIALIS
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN B ASN GLYCOSYLATION SITE
CY3 F CYS 2-AMINO-3-MERCAPTO-PROPIONAMIDE
Ligand Molecules
Primary Citation
Structures of Aplysia Achbp Complexes with Nicotinic Agonists and Antagonists Reveal Distinctive Binding Interfaces and Conformations.
Embo J. 24 3635 ? (2005)
PMID: 16193063 DOI: 10.1038/SJ.EMBOJ.7600828

Abstact

Upon ligand binding at the subunit interfaces, the extracellular domain of the nicotinic acetylcholine receptor undergoes conformational changes, and agonist binding allosterically triggers opening of the ion channel. The soluble acetylcholine-binding protein (AChBP) from snail has been shown to be a structural and functional surrogate of the ligand-binding domain (LBD) of the receptor. Yet, individual AChBP species display disparate affinities for nicotinic ligands. The crystal structure of AChBP from Aplysia californica in the apo form reveals a more open loop C and distinctive positions for other surface loops, compared with previous structures. Analysis of Aplysia AChBP complexes with nicotinic ligands shows that loop C, which does not significantly change conformation upon binding of the antagonist, methyllycaconitine, further opens to accommodate the peptidic antagonist, alpha-conotoxin ImI, but wraps around the agonists lobeline and epibatidine. The structures also reveal extended and nonoverlapping interaction surfaces for the two antagonists, outside the binding loci for agonists. This comprehensive set of structures reflects a dynamic template for delineating further conformational changes of the LBD of the nicotinic receptor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures